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Introduction
Ectopic neurohypophysis is frequently associated 
with anterior pituitary hormone deficiencies. Isolated growth
hormone deficiency (GHD) or multiple pituitary hormone
deficiency (MPHD), in which GHD is associated with one or
more other anterior pituitary hormone deficiencies, may
develop in these cases. Although the etiology is unclear,
traumatic birth, breech delivery and genetic factors have all
been considered as possible factors (1,2). Some of the
genetic factors include LHX4, HESX1, GLI2, GH-1, GH
releasing hormone (GHRH) receptor, POU1F1, PROP-1and
SOX3 mutations and have been shown to be important in
the development of the pituitary gland. However, studies
have failed to implicate a genetic factor in 95% of cases of
ectopic neurohypophysis associated with GHD (1,2,3,4,5).
In the present study, nonsyndromic cases with ectopic 
neurohypophysis were evaluated with respect to renal
developmental anomalies, while the etiology of GHD was
being investigated.
Materials and Methods
Patients
Two-hundred and thirteen cases followed between
January 1990 and December 2007 at the Pediatric
Endocrinology Department of Ege University Faculty of
Medicine with the diagnosis of GHD were included in 
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retrospectively evaluated. Of the total group, 20 
(9.3%) cases (7 girls and 13 boys), in whom ectopic 
neurohypophysis was detected via magnetic resonance
imaging (MRI), were included in this study. We analyzed the
data regarding chronologic age at the time of diagnosis,
standard deviation scores (SDSs) for height and body 
mass index (BMI) at the time of diagnosis, history of
parental consanguinity, difficult birth history, family history
of short stature, presence of other pituitary hormone 
deficiencies or additional anomalies other than ectopic 
neurohypophysis and presence of renal anomalies.
Sagittal and coronal 3-mm-thick slices of the pituitary
area were obtained via MRI. All MRI scans were assessed
by pediatric neuroradiologists who were not blinded to the
clinical information.
Two standard GH stimulation tests were performed
with insulin and levodopa (L-DOPA). In one neonate, plasma
GH levels were measured during spontaneous 
hypoglycemia. A peak value of less than 10 ng/mL in two
tests was regarded as confirmatory for the diagnosis of
GHD. Adrenocorticotropic hormone (ACTH) deficiency was
diagnosed based on a cortisol level of less than 5 μg/dL and
a peak cortisol level of less than 25 μg/dL on ACTH 
test. The diagnosis of thyroid-stimulating hormone (TSH)
deficiency was based on a free thyroxine (fT4) level of less
than 0.8 ng/dL in combination with a normal TSH 
level. Moreover, patients with TSH levels below the normal
range were also diagnosed as having TSH deficiency.
Thyrotropin-releasing hormone (TRH) stimulation test 
(7 μg/kg) was also used in the diagnosis of TSH deficiency.
Hypogonadotropic hypogonadism was suspected 
when both luteinizing hormone (LH) and follicle-stimulating
hormone (FSH) responses to LH-releasing hormone (LHRH)
stimulation test (100 μg/m2) were flat in pubertal patients.
Basal and stimulated levels of cortisol, ACTH, TSH, 
prolactin (PRL), FSH, and LH were measured at sequential
time points (15, 30, 60 and 90 minute after stimulation).
Each hormone was measured by immunochemiluminescent
assay and radioluminescence. Renal anomalies were 
examined by experienced radiologists via ultrasonography
(US). In case of pathological findings on US, the presence
of renal anomalies was confirmed via renal scintigraphy and
intravenous pyelography (IVP).
This study was conducted according to the principles of
the Declaration of Helsinki. 
Results
The mean age of the patients at the time of diagnosis
was 11.3±4.7 years (range, 0.2-18.1 years). The mean SDS
for height at the time of diagnosis was -4.2±1.5 and the
mean SDS for BMI at the time of diagnosis was -0.2±1.2.
Five (20%) of the cases had a family history of short stature
and two (10%) had a history of parental consanguinity. Two
cases had a history of difficult birth. 
Endocrinological evaluation of the patients, in whom
ectopic neurohypophysis was detected on MRI, revealed
that five (20%) cases had isolated GHD and 15 (80%) had
MPHD. GHD was followed by TSH deficiency (13/20; 65%),
FSH-LH deficiency (9/20; 45%) and ACTH deficiency (4/20;
20%), in decreasing order.
MRI scans revealed stalk formation in three cases. One
of these cases had isolated GHD and two had MPHD.
MPHD was determined in all of the 17 cases without stalk
formation on MRI.
Examination of the patients for renal anomalies revealed
renal anomalies in three (15%) cases: unilateral renal 
agenesis in one case, renal hypoplasia in one case, and 
double collecting system and unilateral renal agenesis in
one case. All of the cases with renal anomalies had also
MPHD.
Two patients had testicular hypoplasia, one case 
had chromosomal abnormality [46, XX/47, XX + mar (6)
karyotype], and one case had Fanconi anemia. Table 1
shows the clinical characteristics, endocrinological 
deficiencies of the patients as well as the presence of renal
and additional anomalies. None of the patients had a family
history of renal anomalies. 
Discussion
Ectopic positioning of the posterior lobe of the pituitary
gland is a developmental anomaly and may lead to pituitary
hormone deficiencies. Ectopic neurohypophysis has 
generally been reported as sporadic cases and, in the 
majority of cases the etiology is unknown (1,2,3,4,5).
However, perinatal trauma, such as difficult birth and
breech delivery, has been considered responsible. These
traumatic factors may cause pituitary stalk transection and
ectopic posterior lobe formation after axonal reorganization
(6). In this study, two cases had a history of difficult birth.
Many studies have reported concurrent cranial anomalies
such as craniofacial dysmorphism, septo-optic dysplasia
and Pallister-Hall syndrome, Chiari 1 malformation,
Dubowitz syndrome and Worster-Drought syndrome in
cases with ectopic neurohypophysis (3,4,5,6,7). LHX4,
HESX1, GLI2 and SOX3 mutations were detected in some
of these cases (1,2,3,4,5,6,7). Moreover, previous studies
have also reported concurrent extracranial anomalies such
as arthrogryposis multiplex congenita (8), Fanconi anemia
(9), and situs inversus totalis (10). In a study performed by
Simon et al (7), unilateral renal hypoplasia and ectopia was
found in one of 60 patients with ectopic neurohypophysis.
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(15%) out of 20 cases of ectopic neurohypophysis.
Recently, a number of transcription factors that are
involved in the development of the pituitary gland both in
humans and in animals have been identified. However, the
underlying genetic factor still remains to be determined in
the majority of cases with ectopic neurohypophysis
(2,3,4,5,6). In humans, mutations in transcription factors
including PIT1, PROP1, HESX1, LHX3 and LHX4 have been
associated with a broad spectrum of clinical phenotypes
(11). Among these genes, the mutations of LHX4 (12),
HESX1 (13,14), GLI2 and SOX3 (4,15) have been reported in
patients with pituitary hormone deficiency and ectopic 
neurohypophysis.
In the present study, the high frequency of renal 
anomalies including renal agenesis and hypoplasia in
patients with ectopic neurohypophysis was noteworthy. In
the general population, the frequency of renal anomalies is
three to six per 1 000 live births (16).  Previous studies have
reported mutations in various genes, such as LHX1 (17),
LIM 1(18), SALL1 (19), FGFR1, FGFR2 (20), SIX1 (21), 
SIX2 (22), EYA1 (23), and GLI3 (24), leading to renal 
developmental anomalies. It is well-known that a mutation
during the early stages of embryonic development is likely
to affect more than one system. Common genes may be
responsible for the development of ectopic neurohypophysis
and renal anomalies. In a study conducted by Johnston et al
(24), GLI3 mutations were identified in Pallister-Hall 
syndrome cases with pituitary developmental anomalies
and renal agenesis or dysplasia, and it was suggested that
this single gene mutation affected both the pituitary gland
and the renal system. Furthermore, renal agenesis/dysplasia
has been reported in Kallmann syndrome caused by KALL1
or FGFR1 gene mutations. Unilateral renal agenesis has
been described in patients with Kallmann syndrome. Kirk et
al (25) reported a systematic study of kidneys in 17 affected
individuals from six families with Kallmann syndrome,
including a family with Kallmann syndrome associated with
ichthyosis and interstitial deletion within the short arm of
the X chromosome. In that particular study, unilateral renal
agenesis was found in six males from four families.
Moreover, in two families (including a family in which all
four patients had normal kidneys), there were male infants
who died because of bilateral renal agenesis. In the 
family with Kallmann syndrome associated with ichthyosis,
unilateral renal agenesis was found in two of four affected
individuals. These four individuals all had the same 
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Table 1. Clinical features, endocrinological deficiencies, renal and other additional anomalies of the patients
Case Gender Age at diagnosis (years) Endocrinological deficiency Additional anomalies Renal anomalies
1 M 13.8 TSH, GH None None
2 F 15.4 TSH, GH None None
3 M 4.4 ACTH, GH, FSH-LH Fanconi anemia Right renal agenesis
4 M 11.5 GH Right hypoplastic testis None
5 M 10.4 TSH, GH None None
6 F 10.1 TSH, GH, FSH-LH None None
7 M 0.16 GH, ACTH, TSH None Renal agenesis
8 F 9.7 GH 46, XX/47, XX + mar (6) None
9 M 17.1 GH, TSH, FSH-LH None None
10 F 15.6 GH, TSH, FSH-LH None None
11 M 13.2 GH, TSH, FSH-LH None None
12 F 11.7 GH, TSH, FSH-LH None None
13 F 18.1 GH, FSH-LH None None
14 M 8.3 GH, TSH None None
15 M 7.9 GH, TSH, FSH-LH None None
16 M 17.3 GH, TSH, ACTH, FSH-LH Hypoplastic testis  Renal hypoplasia
17 F 9.7 GH None None
18 M 6.7 TSH, FSH-LH None None
19 M 14.1 GH None None
20 M 14.2 GH None None
F: female; M: male; LH: luteinizing hormone;  FSH: follicle-stimulating hormone; ACTH: adrenocorticotropic hormone;  TSH: thyroid-stimulating hormone; GH: growth hormone X-chromosome deletion. Presumably, normal renal 
development requires expression of the Kallmann product
(Kalig1/AMDLX), but mutation or absence of this product is
not invariably associated with renal agenesis (25,26,27).
LHX1 gene is expressed in the primitive streak and 
prechordal mesoderm and, later, in the developing kidney
and in portions of the central nervous system. A knockout
experiment showed that LHX1 is an essential regulator of
the vertebrate head organizer (17).
In conclusion, ectopic neurohypophysis is a diagnosis that
should not be disregarded in cases with GHD. Further detailed
studies are warranted to elucidate the etiology of ectopic 
neurohypophysis and other anomalies that may accompany
this entity. The probability of the association of pituitary 
development anomalies with LHX1, LIM 1, BMP 4, AGTR2,
SALL1, FGFR1, FGFR2 and SIX 1 gene mutations that have
been shown to cause renal development anomalies and/or 
mutations of one of these gene families should be taken into
consideration, and further studies should be planned. In the
present study, increased prevalence of renal anomalies 
associated with ectopic neurohypophysis was highlighted and,
the probability of the presence of common underlying genetic 
factors was emphasized.
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